Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 384 followers
Latest posts
Last updated about 1 hour ago
Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy
about 1 hour ago
Pfizer has rolled out detailed trial data suggesting Tukysa could be part...
CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development
about 18 hours ago
Bora and Corealis are joining forces to create a new end-to-end CDMO...
Genentech uncovers ‘Hidden GeMS’ in latest iteration of multiple sclerosis visibility drive
about 18 hours ago
With a new edition of a long-running awareness campaign, Genentech is drawing...
Roll Tide: Lilly selects Alabama site as location for $6B API facility
about 19 hours ago
Eli Lilly has unveiled the location of the third of its four...
Roll Tide: Lilly selects Alabama site as location for $6B API facility
about 20 hours ago
Eli Lilly has unveiled the location of the third of its four...
Biocon buys out Viatris and others from biosimilar subsidiary
about 20 hours ago
Returning its stake in Biocon Biologics allows Viatris to re-enter the biosimilar...
FDA now has Merck, AZ and Sanofi RSV shots for infants in its crosshairs: Reuters
about 22 hours ago
As an FDA official said that the agency has evidence that links...
Biosecure legislation makes way into key US defense bill, teeing up potential China biopharma constraints in '26
about 23 hours ago
Over the weekend, the Senate and House released the final text of...
With eye on AI, Imre hires Nadine Lafond from Ogilvy Health to fill CEO vacancy
1 day ago
Ad agency Imre has filled the vacancy at the top of its...
Its future still in limbo, CSL Seqirus debuts $1B flu shot, antivenom plant in Australia
1 day ago
CSL, which earlier this year shelved plans to put its CSL Seqirus...
Once public, now private, Gamida Cell scores 2nd FDA nod for stem cell therapy Omisirge
1 day ago
Transformed Gamida Cell has scored an expansion for Omisirge, with the FDA...
ASH: Lilly oncology chief sees sweet spot for Jaypirca in second-line CLL despite first-line trial wins
1 day ago
Despite holding positive phase 3 data that position its BTK inhibitor Jaypirca...